TXMD
Therapeuticsmd·NASDAQ
--
--(--)
--
--(--)
7.41 / 10
Outperform
Money-flow analysis registers 7.41/10, indicating robust fund-flow characteristics. Although the overall trend is labeled negative, the high score reflects positive momentum in smaller trade sizes and a lack of large-scale outflows. This healthy liquidity supports the stock but does not yet override the neutral technical and mixed fundamental signals.
Fund Flow Rating
Is money flowing into or out of TXMD?
- TXMD holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.41/10 (Outperform).
